Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Kedudukan dalam Saham #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Harga Saham
$44.42
Disegerakkan terakhir: 2026-08-25
Modal Pasaran
$5.90B
Perubahan (1 hari)
2.66%
Perubahan (1 tahun)
344.66%
Negara
US
Perdagangan Definium Therapeutics, Inc. (DFTX)

Kategori

Sejarah pecahan saham untuk Definium Therapeutics, Inc. (DFTX)
Saham Definium Therapeutics, Inc. (simbol: DFTX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 26, 2026.
Satu saham DFTX yang dibeli sebelum Aug 26, 2026 kini bersamaan dengan 0 saham DFTX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH